175 related articles for article (PubMed ID: 25682988)
21. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.
Cheng A; Nazarian S; Brinker JA; Tompkins C; Spragg DD; Leng CT; Halperin H; Tandri H; Sinha SK; Marine JE; Calkins H; Tomaselli GF; Berger RD; Henrikson CA
Heart Rhythm; 2011 Apr; 8(4):536-40. PubMed ID: 21147261
[TBL] [Abstract][Full Text] [Related]
22. Pacemaker or defibrillator surgery without interruption of anticoagulation.
Birnie DH; Healey JS; Wells GA; Verma A; Tang AS; Krahn AD; Simpson CS; Ayala-Paredes F; Coutu B; Leiria TL; Essebag V;
N Engl J Med; 2013 May; 368(22):2084-93. PubMed ID: 23659733
[TBL] [Abstract][Full Text] [Related]
23. Perioperative management of oral anticoagulation in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator.
Afzal MR; Mehta D; Evenson C; Pinkhas D; Badin A; Patel D; Essandoh MK; Godara H; Tyler J; Houmsse M; Liu Z; Kalbfleisch SJ; Hummel JD; Augostini R; Weiss R; Daoud EG; Okabe T
Heart Rhythm; 2018 Apr; 15(4):520-523. PubMed ID: 29146276
[TBL] [Abstract][Full Text] [Related]
24. Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies.
Proietti R; Porto I; Levi M; Leo A; Russo V; Kalfon E; Biondi-Zoccai G; Roux JF; Birnie DH; Essebag V
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1461-79. PubMed ID: 25967723
[TBL] [Abstract][Full Text] [Related]
25. Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study).
Malagù M; Trevisan F; Scalone A; Marcantoni L; Sammarco G; Bertini M
Am J Cardiol; 2017 Apr; 119(7):1036-1040. PubMed ID: 28153344
[TBL] [Abstract][Full Text] [Related]
26. Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).
Turagam MK; Nagarajan DV; Bartus K; Makkar A; Swarup V
J Interv Card Electrophysiol; 2017 Aug; 49(2):197-204. PubMed ID: 28413854
[TBL] [Abstract][Full Text] [Related]
27. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators.
Robinson M; Healey JS; Eikelboom J; Schulman S; Morillo CA; Nair GM; Baranchuk A; Ribas S; Evans G; Connolly SJ; Turpie AG
Pacing Clin Electrophysiol; 2009 Mar; 32(3):378-82. PubMed ID: 19272069
[TBL] [Abstract][Full Text] [Related]
28. Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy.
Pecha S; Ayikli A; Wilke I; Hakmi S; Yildirim Y; Gosau N; Reichenspurner H; Willems S; Aydin MA
Heart Vessels; 2018 Apr; 33(4):441-446. PubMed ID: 29030709
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study.
Sant'anna RT; Leiria TL; Nascimento T; Sant'anna JR; Kalil RA; Lima GG; Verma A; Healey JS; Birnie DH; Essebag V
Pacing Clin Electrophysiol; 2015 Apr; 38(4):417-23. PubMed ID: 25546244
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion.
Schulman S; Schoenberg J; Divakara Menon S; Spyropoulos AC; Healey JS; Eikelboom JW
Thromb Res; 2013 Apr; 131(4):300-3. PubMed ID: 23369688
[TBL] [Abstract][Full Text] [Related]
31. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.
Schulman S; Healey JS; Douketis JD; Delaney J; Morillo CA
Thromb Res; 2014 Oct; 134(4):814-8. PubMed ID: 25127655
[TBL] [Abstract][Full Text] [Related]
32. Impact of peri-procedural management of direct oral anticoagulants on pocket haematoma after cardiac electronic device implantation: the StimAOD multicentre prospective study.
Martin AC; Weizman O; Sellal JM; Algalarrondo V; Amara W; Bouzeman A; Gandjbakhch E; Lellouche N; Louembe J; Menet A; Roumegou P; Treguer F; Godier A; Boveda S; Garcia R; Marijon E
Europace; 2023 May; 25(5):. PubMed ID: 36932714
[TBL] [Abstract][Full Text] [Related]
33. Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices.
Rowley CP; Bernard ML; Brabham WW; Netzler PC; Sidney DS; Cuoco F; Sturdivant JL; Leman RB; Wharton JM; Gold MR
Am J Cardiol; 2013 Apr; 111(8):1165-8. PubMed ID: 23360767
[TBL] [Abstract][Full Text] [Related]
34. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
Larson BJ; Zumberg MS; Kitchens CS
Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
[TBL] [Abstract][Full Text] [Related]
35. The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysis.
Yang X; Wang Z; Zhang Y; Yin X; Hou Y
Europace; 2015 Jul; 17(7):1076-84. PubMed ID: 25713013
[TBL] [Abstract][Full Text] [Related]
36. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
Li HK; Chen FC; Rea RF; Asirvatham SJ; Powell BD; Friedman PA; Shen WK; Brady PA; Bradley DJ; Lee HC; Hodge DO; Slusser JP; Hayes DL; Cha YM
Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
[TBL] [Abstract][Full Text] [Related]
37. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
[TBL] [Abstract][Full Text] [Related]
38. Pocket related complications following cardiac electronic device implantation in patients receiving anticoagulation and/or dual antiplatelet therapy: prospective evaluation of different preventive strategies.
Awada H; Geller JC; Brunelli M; Ohlow MA
J Interv Card Electrophysiol; 2019 Apr; 54(3):247-255. PubMed ID: 30460588
[TBL] [Abstract][Full Text] [Related]
39. Perioperative management of anticoagulation during device implantation-the UK perspective.
de Bono J; Nazir S; Ruparelia N; Bashir Y; Betts T; Rajappan K
Pacing Clin Electrophysiol; 2010 Apr; 33(4):389-93. PubMed ID: 20132500
[TBL] [Abstract][Full Text] [Related]
40. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
